News | April 28, 2026
From losses to lift-off: Astec gains ground in Q4 FY26
The company reported consolidated total income of Rs. 161.3 crore in Q4 FY26, a strong jump from Rs. 120.3 crore in the same period last year
The company reported consolidated total income of Rs. 161.3 crore in Q4 FY26, a strong jump from Rs. 120.3 crore in the same period last year
The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
Move amid evidence of widespread reporting gaps
The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students
Subscribe To Our Newsletter & Stay Updated
